Entrada Therapeutics, Inc. (TRDA) shares ended the last trading session 5.6% higher at $6.64. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 11.5% loss over the past four weeks. The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> The sudden price rise can be attributed to growing investor optimism related to the company's lead oli ...